cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.6084/m9.figshare.12248882.v1
title: Supplementary Material for: Correspondence between Capnovolumetric and Conventional Lung Function Parameters in the Diagnosis of Obstructive Airway Diseases

description: <b><i>Background:</i></b> Capnovolumetry is of interest as a method for the diagnosis of obstructive airway diseases, requiring little cooperation from the patient. <b><i>Objective:</i></b> To help in the interpretation of capnovolumetric parameters, we aimed to identify their correspondence to conventional lung function indices. <b><i>Methods:</i></b> We studied 978 patients from a diagnostic study with complete functional data and the clinical diagnosis of asthma, chronic obstructive pulmonary disease (COPD), or no respiratory disease. Using path analysis, four capnovolumetric parameters (slope of expiratory phase 3, ratio of slopes of phases 3 and 2, volume of phase 2, and the ratio area/volume of phase 3) previously identified as predictors of airway obstruction in terms of spirometry and body ple­thysmography, were analyzed regarding their relationship to each other and the diagnostic categories of asthma or COPD versus control, or obstruction versus no obstruction. We then identified four lung function parameters showing relationships as much as possible isomorphic to those between capnovolumetric parameters. <b><i>Results:</i></b> The four capnovolumetric parameters were related to COPD and obstruction via both direct and indirect influences, but only two of them to asthma. Regarding the correspondence to lung function parameters, the slope of expiratory phase 3 corresponded best to the ratio of residual volume to total lung capacity, the ratio of slopes of phases 3 and 2 to forced expiratory volume in 1 s, the volume of phase 2 to forced expired flow at 50% of vital capacity, and the ratio area/volume of phase 3 to forced vital capacity. <b><i>Conclusions:</i></b> Our results indicated an intricate relationship of capnovolumetric parameters to each other and to airway obstruction, asthma, or COPD. The correspondence to conventional lung function measures seemed to reflect the entities lung hyperinflation, overall ventilatory impairment, bronchoconstriction, and ventilated lung volume, in that order. These findings might be helpful for clinicians in the interpretation of capnovolumetry.
DOI: 10.6084/m9.figshare.12248723
title: Encuesta uso de RFID en Bibliotecas Públicas 2020

description: Encuesta realizada a las biblioteca públicas de España e Iberoamérica en marzo-abril 2020 sobre el uso de la tecnología RFID - Survey of public libraries in Spain and Latin America in March-April 2020 about the use of RFID technology
DOI: 10.6084/m9.figshare.12248801.v1
title: Supplementary Material for: International Assessment of DSM-5 and ICD-11 Personality Disorder Traits: Toward a Common Nosology in DSM-5.1

description: <b><i>Introduction:</i></b> The DSM-5 Alternative Model of Personality Disorders (AMPD) and the ICD-11 classification of personality disorders (PD) are largely commensurate and, when combined, they delineate 6 trait domains: negative affectivity, detachment, antagonism/dissociality, disinhibition, anankastia, and psychoticism. <b><i>Objective:</i></b> The present study evaluated the international validity of a brief 36-item patient-report measure that portrays all 6 domains simultaneously including 18 primary subfacets. <b><i>Methods:</i></b> We developed and employed a modified version of the Personality Inventory for DSM-5 – Brief Form Plus (PID5BF+). A total of 16,327 individuals were included, 2,347 of whom were patients. The expected 6-factor structure of facets was initially investigated in samples from Denmark (<i>n</i> = 584), Germany (<i>n</i> = 1,271), and the USA (<i>n</i> = 605) and subsequently replicated in both patient- and community samples from Italy, France, Switzerland, Belgium, Norway, Portugal, Spain, Poland, Czech Republic, the USA, and Brazil. Associations with interview-rated DSM-5 PD categories were also investigated. <b><i>Results:</i></b> Findings generally supported the empirical soundness and international robustness of the 6 domains including meaningful associations with familiar interview-rated PD types. <b><i>Conclusions:</i></b> The modified PID5BF+ may be employed internationally by clinicians and researchers for brief and reliable assessment of the 6 combined DSM-5 and ICD-11 domains, including 18 primary subfacets. This 6-domain framework may inform a future nosology for DSM-5.1 that is more reasonably aligned with the authoritative ICD-11 codes than the current DSM-5 AMPD model. The 36-item modified PID5BF+ scoring key is provided in online supplementary Appendix A see www.karger.com/doi/10.1159/000507589 (for all online suppl. material).
DOI: 10.6084/m9.figshare.12248675
title: Supplementary Material for: Potential of Lenvatinib for an Expanded Indication from the REFLECT Trial in Patients with Advanced Hepatocellular Carcinoma

description: <b><i>Background:</i></b> The present study aimed to assess the efficacy and safety of lenvatinib and verify the possibility of lenvatinib for the expanded indication from the REFLECT trial in patients with advanced hepatocellular carcinoma (HCC) in real-world practice, primarily focusing on the population that was excluded in the REFLECT trial. <b><i>Methods:</i></b> We retrospectively collected data on patients with advanced HCC who were administered lenvatinib in 7 institutions in Japan. <b><i>Results:</i></b> Of 152 advanced HCC patients, 95 and 57 patients received lenvatinib in first-line and second- or later-line systemic therapies, respectively. The median progression-free survival in Child-Pugh class A patients was nearly equal between first- and second- or later-line therapies (5.2 months; 95% CI 3.7–6.9 for first line, 4.8 months; 95% CI 3.8–5.9 for second or later line, <i>p</i> = 0.933). According to the modified Response Evaluation Criteria in Solid Tumors, the objective response rate of 27 patients (18%) who showed a high burden of intrahepatic lesions (i.e., main portal vein and/or bile duct invasion or 50% or higher liver occupation) at baseline radiological assessment was 41% and similar with that of other population. The present study included 20 patients (13%) with Child-Pugh class B. These patients observed high frequency rates of liver function-related adverse events due to lenvatinib. The 8-week dose intensity of lenvatinib had a strong correlation with liver function according to both the Child-Pugh and albumin – bilirubin scores. <b><i>Conclusion:</i></b> Lenvatinib had potential benefits for patients with advanced HCC with second- or later-line therapies and a high burden of intrahepatic lesions. Dose modification should be paid increased attention among patients with poor liver function, such as Child-Pugh class B patients.
DOI: 10.6084/m9.figshare.12248702
title: SkeleDock: Table S1

description: SkeleDock: Table S1 <br>
DOI: 10.6084/m9.figshare.12248723.v1
title: Encuesta uso de RFID en Bibliotecas Públicas 2020

description: Encuesta realizada a las biblioteca públicas de España e Iberoamérica en marzo-abril 2020 sobre el uso de la tecnología RFID - Survey of public libraries in Spain and Latin America in March-April 2020 about the use of RFID technology
DOI: 10.6084/m9.figshare.12248675.v1
title: Supplementary Material for: Potential of Lenvatinib for an Expanded Indication from the REFLECT Trial in Patients with Advanced Hepatocellular Carcinoma

description: <b><i>Background:</i></b> The present study aimed to assess the efficacy and safety of lenvatinib and verify the possibility of lenvatinib for the expanded indication from the REFLECT trial in patients with advanced hepatocellular carcinoma (HCC) in real-world practice, primarily focusing on the population that was excluded in the REFLECT trial. <b><i>Methods:</i></b> We retrospectively collected data on patients with advanced HCC who were administered lenvatinib in 7 institutions in Japan. <b><i>Results:</i></b> Of 152 advanced HCC patients, 95 and 57 patients received lenvatinib in first-line and second- or later-line systemic therapies, respectively. The median progression-free survival in Child-Pugh class A patients was nearly equal between first- and second- or later-line therapies (5.2 months; 95% CI 3.7–6.9 for first line, 4.8 months; 95% CI 3.8–5.9 for second or later line, <i>p</i> = 0.933). According to the modified Response Evaluation Criteria in Solid Tumors, the objective response rate of 27 patients (18%) who showed a high burden of intrahepatic lesions (i.e., main portal vein and/or bile duct invasion or 50% or higher liver occupation) at baseline radiological assessment was 41% and similar with that of other population. The present study included 20 patients (13%) with Child-Pugh class B. These patients observed high frequency rates of liver function-related adverse events due to lenvatinib. The 8-week dose intensity of lenvatinib had a strong correlation with liver function according to both the Child-Pugh and albumin – bilirubin scores. <b><i>Conclusion:</i></b> Lenvatinib had potential benefits for patients with advanced HCC with second- or later-line therapies and a high burden of intrahepatic lesions. Dose modification should be paid increased attention among patients with poor liver function, such as Child-Pugh class B patients.
DOI: 10.6084/m9.figshare.12248702.v1
title: SkeleDock: Table S1

description: SkeleDock: Table S1 <br>
DOI: 10.6084/m9.figshare.12248618
title: Supplementary Material for: Tenofovir Treatment Has Lower Risk of Hepatocellular Carcinoma than Entecavir Treatment in Patients with Chronic Hepatitis B: A Systematic Review and Meta-Analysis

description: <b><i>Purpose:</i></b> Tenofovir (TDF) and entecavir (ETV) are both equally recommended as first-line treatments for patients with chronic hepatitis B (CHB). They have comparable efficacy in virologic response, but their effect on the development of hepatocellular carcinoma (HCC) in CHB is controversial. Therefore, we aimed to compare TDF and ETV evaluating the risk of HCC development in CHB patients. <b><i>Methods:</i></b> A systematic literature search was conducted up to November 2019 in MEDLINE/PubMed, SCOPUS, and Web of Science databases without language and time restrictions. DerSimonian and Laird random-effects models were used to estimate combined hazard ratios (HRs) and 95% CIs. <b><i>Results:</i></b> Seven studies containing 35,785 participants were included in this systematic review and meta-analysis. The pooled HR (95% CI) of HCC in the patients who used TDF versus patients who used ETV was 0.75 (0.56–0.96). There was no significant heterogeneity detected among the included studies results (<i>I</i><sup>2</sup> = 47.5%). There was no significant publication bias detected among the included studies (Begg’s <i>p</i> = 0.88 and Egger’s regression test <i>p</i> = 0.96). <b><i>Conclusions:</i></b> Evidence to date suggests that TDF treatment is associated with significantly fewer cases of HCC when compared to ETV.
DOI: 10.6084/m9.figshare.12248618.v1
title: Supplementary Material for: Tenofovir Treatment Has Lower Risk of Hepatocellular Carcinoma than Entecavir Treatment in Patients with Chronic Hepatitis B: A Systematic Review and Meta-Analysis

description: <b><i>Purpose:</i></b> Tenofovir (TDF) and entecavir (ETV) are both equally recommended as first-line treatments for patients with chronic hepatitis B (CHB). They have comparable efficacy in virologic response, but their effect on the development of hepatocellular carcinoma (HCC) in CHB is controversial. Therefore, we aimed to compare TDF and ETV evaluating the risk of HCC development in CHB patients. <b><i>Methods:</i></b> A systematic literature search was conducted up to November 2019 in MEDLINE/PubMed, SCOPUS, and Web of Science databases without language and time restrictions. DerSimonian and Laird random-effects models were used to estimate combined hazard ratios (HRs) and 95% CIs. <b><i>Results:</i></b> Seven studies containing 35,785 participants were included in this systematic review and meta-analysis. The pooled HR (95% CI) of HCC in the patients who used TDF versus patients who used ETV was 0.75 (0.56–0.96). There was no significant heterogeneity detected among the included studies results (<i>I</i><sup>2</sup> = 47.5%). There was no significant publication bias detected among the included studies (Begg’s <i>p</i> = 0.88 and Egger’s regression test <i>p</i> = 0.96). <b><i>Conclusions:</i></b> Evidence to date suggests that TDF treatment is associated with significantly fewer cases of HCC when compared to ETV.
DOI: 10.6084/m9.figshare.12248594
title: Supplementary Material for: Variability of Thyroid Measurements from Ultrasound and Laboratory in a Repeated Measurements Study

description: <b><i>Background:</i></b> Variability of measurements in medical research can be due to different sources. Quantification of measurement errors facilitates probabilistic sensitivity analyses in future research to minimize potential bias in epidemiological studies. We aimed to investigate the variation of thyroid-related outcomes derived from ultrasound (US) and laboratory analyses in a repeated measurements study. <b><i>Subjects and Methods:</i></b> Twenty-five volunteers (13 females, 12 males) aged 22–70 years were examined once a month over 1 year. US measurements included thyroid volume, goiter, and thyroid nodules. Laboratory measurements included urinary iodine concentrations and serum levels of thyroid-stimulating hormone (TSH), free triiodothyronine (fT3), free thyroxine (fT4), and thyroglobulin. Variations in continuous thyroid markers were assessed as coefficient of variation (CV) defined as mean of the individual CVs with bootstrapped confidence intervals and as intraclass correlation coefficients (ICCs). Variations in dichotomous thyroid markers were assessed by Cohen’s kappa. <b><i>Results:</i></b> CV was highest for urinary iodine concentrations (56.9%), followed by TSH (27.2%), thyroglobulin (18.2%), thyroid volume (10.5%), fT3 (8.1%), and fT4 (6.3%). The ICC was lowest for urinary iodine concentrations (0.42), followed by fT3 (0.55), TSH (0.64), fT4 (0.72), thyroid volume (0.87), and thyroglobulin (0.90). Cohen’s kappa values for the presence of goiter or thyroid nodules were 0.64 and 0.70, respectively. <b><i>Conclusion:</i></b> Our study provides measures of variation for thyroid outcomes, which can be used for probabilistic sensitivity analyses of epidemiological data. The low intraindividual variation of serum thyroglobulin in comparison to urinary iodine concentrations emphasizes the potential of thyroglobulin as marker for the iodine status of populations.
DOI: 10.6084/m9.figshare.12248567
title: Quercus faginea chorology

description: Distribution map of Portuguese oak (<i>Quercus faginea</i>)<br>These maps were produced by combining numerous and heterogeneous data collected from atlas monographs providing complete species distribution maps, from national to regional atlases, occurrence geo-databases, scientific and grey literature.The maps were created using ESRI shapefiles (*.shp, *.shx, *.dbf, *.prj files) archived in the ZIP file. Species range is mapped with polygon features (name suffix "plg"), which define continuous areas of occupancy of the species, and with point features (name suffix "pnt"), which identify more fragmented and isolated populations. If synanthropic occurrences are reported outside the species natural range, additional point and/or polygon shapefiles are also present (suffix "syn").Polygon borders delimiting species ranges are generalized across the mainland and sea boundaries. This offers the possibility to mask sea areas or to clip and extract the terrestrial range parts using GIS data layers of the users' choice. An additional version of polygon ranges are clipped with a coastline (name suffix "clip"), which have been derived from Natural Earth dataset "Admin 0 - Countries" 1:50M version 4.1.0 (https://www.naturalearthdata.com)<br>Please cite as:<br>Caudullo, G., Welk, E., San-Miguel-Ayanz, J., 2017. Chorological maps for the main European woody species. Data in Brief 12, 662-666. DOI: doi.org/10.1016/j.dib.2017.05.007<br><br>Additional information and used references are on 'supplementary materials' document:<br>https://doi.org/10.6084/m9.figshare.5091901<br><br>Chorological maps are part of the "European Atlas of Forest Tree Species" project:<br>https://w3id.org/mtv/FISE-Comm/v01<br>
DOI: 10.6084/m9.figshare.12248555
title: TABLAS CON MUESTRAS Y ANALISIS

description: Tablas de muestra y análisis<br>
DOI: 10.6084/m9.figshare.12248555.v1
title: TABLAS CON MUESTRAS Y ANALISIS

description: Tablas de muestra y análisis<br>
DOI: 10.6084/m9.figshare.12248363
title: Supplementary Table 2 from Construction and forensic application of 20 highly polymorphic microhaplotypes

description: The tests of Hardy-Weinberg equilibrium and linkage disequilibrium for microhaplotype loci.
DOI: 10.6084/m9.figshare.12248369
title: Supplementary Table 5 from Construction and forensic application of 20 highly polymorphic microhaplotypes

description: The allele frequencies of tri-allelic SNPs for each microhaplotype.
DOI: 10.6084/m9.figshare.12248567.v1
title: Quercus faginea chorology

description: Distribution map of Portuguese oak (<i>Quercus faginea</i>)<br>These maps were produced by combining numerous and heterogeneous data collected from atlas monographs providing complete species distribution maps, from national to regional atlases, occurrence geo-databases, scientific and grey literature.The maps were created using ESRI shapefiles (*.shp, *.shx, *.dbf, *.prj files) archived in the ZIP file. Species range is mapped with polygon features (name suffix "plg"), which define continuous areas of occupancy of the species, and with point features (name suffix "pnt"), which identify more fragmented and isolated populations. If synanthropic occurrences are reported outside the species natural range, additional point and/or polygon shapefiles are also present (suffix "syn").Polygon borders delimiting species ranges are generalized across the mainland and sea boundaries. This offers the possibility to mask sea areas or to clip and extract the terrestrial range parts using GIS data layers of the users' choice. An additional version of polygon ranges are clipped with a coastline (name suffix "clip"), which have been derived from Natural Earth dataset "Admin 0 - Countries" 1:50M version 4.1.0 (https://www.naturalearthdata.com)<br>Please cite as:<br>Caudullo, G., Welk, E., San-Miguel-Ayanz, J., 2017. Chorological maps for the main European woody species. Data in Brief 12, 662-666. DOI: doi.org/10.1016/j.dib.2017.05.007<br><br>Additional information and used references are on 'supplementary materials' document:<br>https://doi.org/10.6084/m9.figshare.5091901<br><br>Chorological maps are part of the "European Atlas of Forest Tree Species" project:<br>https://w3id.org/mtv/FISE-Comm/v01<br>
DOI: 10.6084/m9.figshare.12248360
title: Supplementary Table 3 from Construction and forensic application of 20 highly polymorphic microhaplotypes

description: The principal forensic statistics of 20 microhaplotypes for 2504 individuals from the 1000 Genome Project.
DOI: 10.6084/m9.figshare.12248369.v1
title: Supplementary Table 5 from Construction and forensic application of 20 highly polymorphic microhaplotypes

description: The allele frequencies of tri-allelic SNPs for each microhaplotype.
DOI: 10.6084/m9.figshare.12248360.v1
title: Supplementary Table 3 from Construction and forensic application of 20 highly polymorphic microhaplotypes

description: The principal forensic statistics of 20 microhaplotypes for 2504 individuals from the 1000 Genome Project.
DOI: 10.6084/m9.figshare.12248363.v1
title: Supplementary Table 2 from Construction and forensic application of 20 highly polymorphic microhaplotypes

description: The tests of Hardy-Weinberg equilibrium and linkage disequilibrium for microhaplotype loci.
DOI: 10.6084/m9.figshare.12248351
title: Supplementary Table 1 from Construction and forensic application of 20 highly polymorphic microhaplotypes

description: The detailed information of specific primers and PCR amplicons size.
DOI: 10.6084/m9.figshare.12248348
title: Supplementary Table 4 from Construction and forensic application of 20 highly polymorphic microhaplotypes

description: The observed alleles and allele frequencies of 20 microhaplotypes for 2554 individuals (2504 from 1000 genome project and 50 unrelated individuals from our study)
DOI: 10.6084/m9.figshare.12248345
title: Supplementary Table 6 from Construction and forensic application of 20 highly polymorphic microhaplotypes

description: The genotypes and CPI values of 12 parent/child duos based on microhaplotype and STR.
DOI: 10.6084/m9.figshare.12248348.v1
title: Supplementary Table 4 from Construction and forensic application of 20 highly polymorphic microhaplotypes

description: The observed alleles and allele frequencies of 20 microhaplotypes for 2554 individuals (2504 from 1000 genome project and 50 unrelated individuals from our study)
DOI: 10.6084/m9.figshare.12248351.v1
title: Supplementary Table 1 from Construction and forensic application of 20 highly polymorphic microhaplotypes

description: The detailed information of specific primers and PCR amplicons size.
DOI: 10.6084/m9.figshare.12248345.v1
title: Supplementary Table 6 from Construction and forensic application of 20 highly polymorphic microhaplotypes

description: The genotypes and CPI values of 12 parent/child duos based on microhaplotype and STR.
DOI: 10.6084/m9.figshare.12248312
title: Dataset for: The importance of incorporating landscape change for predictions of climate-induced plant phenological shifts

description: Data taken from Chisholm et al. (2020): https://doi.org/10.3389/fpls.2020.00759<br>Article abstract: Warming in the high Arctic is occurring at the fastest rate on the planet, raising concerns over how this global change driver will influence plant community composition, the timing of vegetation phenological events, and the wildlife that rely on them. In this region, as much as 50% of near-surface permafrost is composed of thermally sensitive ground ice that when melted produces substantial changes in topography and microbiome conditions. We take advantage of natural variations in permafrost melt to conduct a space-for-time study on Ellesmere Island in northern Canada. We demonstrate that phenological timing can be delayed in thermokarst areas when compared to stable ground, and that this change is a function of both shifting species composition in these vegetation communities, as well as delayed timing within species. These findings suggest that a warming climate could result in an overall broadening of blooming and leafing windows at the landscape level when these delayed timings are taken into consideration with the projected advance of phenological timings in ice-poor areas. We emphasize that the impacts of geomorphic processes on key phenological drivers are essential for enhancing our understanding of community response to climate warming in the high Arctic, with implications for ecosystem functioning and trophic interactions.